NCT03736837 2021-03-15
ALTER-L004
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed
Clinical Trials
5 trialsNCT01878448 2019-05-22
ALTN/STS
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Completed
NCT01874873 2019-05-21
ALTN/MTC
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Completed
NCT02388919 2017-09-18
ALTER0303
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2/3 Completed
NCT01924195 2015-10-28
Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Completed